Active Pharmaceutical Ingredients
Fluoxetine HCl SR Pellets are a modified-release formulation designed to provide a controlled release of fluoxetine over an extended period. These pellets help maintain steady plasma drug levels, improving patient compliance and reducing side effects compared to immediate-release formulations.
| Component | Function |
|---|---|
| Fluoxetine Hydrochloride | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Ethyl Cellulose / Eudragit RS/RL | Sustained-release polymer (controls drug release) |
| Triethyl Citrate / PEG 6000 | Plasticizer (for coating flexibility) |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Fluoxetine HCl SR Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
They are primarily used in the treatment of depression, anxiety disorders, obsessive-compulsive disorder (OCD), panic disorder, bulimia nervosa, and premenstrual dysphoric disorder (PMDD).
Sustained release is typically achieved using ethyl cellulose, Eudragit RS/RL, or HPMC-based coatings.
Yes. Export requires DMF (Drug Master File) or Product Dossier preparation, stability data, and compliance with cGMP manufacturing guidelines.
Pellets are generally packed in HDPE containers, alu-alu strips, or multilayer laminated pouches to protect from moisture, heat, and light.